AKR1C3 and endometrial cancer: For endometrial cancer, positive IHC reactions were seen for AKR1C3 in the cytoplasm and also nucleus of the epithelial cancer cells in endometrioid and nonendometrioid endometrial cancers, including serous, dedifferentiated, carcinosarcomas, clear cell, and mixed carcinoma.